ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia

ClinicalTrials.gov ID: NCT00615433

Public ClinicalTrials.gov record NCT00615433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-and Active Comparator Controlled, Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia.

Study identification

NCT ID
NCT00615433
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
478 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone Drug
  • Lurasidone 40 mg tablets Drug
  • Olanzapine Drug
  • Placebo comparator Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Nov 30, 2009
Completion
Dec 31, 2009
Last update posted
Jun 11, 2015

2008 – 2010

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
K&S Professional Research Services LLC Little Rock Arkansas 72201
Woodland International Research Group, LLC Little Rock Arkansas 72211
Clinical Pharmacological Studies, Inc. Cerritos California 90703
Excell Research Oceanside California 92056
University of California at Irvine Medical Center Orange California 92868
California Clinical Trials Paramount California 90723
CNRI - San Diego, LLC San Diego California 92102
UCSD Medical Center San Diego California 92103
Collaborative Neuroscience Network Inc. Torrance California 90502
Florida Clinical Research Center, LLC Fruitland Park Florida 24731
Segal Institute for Clinical Research North Miami Florida 33161
Atlanta Center for Medical Research Atlanta Georgia 30308
Uptown Research Institute, LLC Chicago Illinois 60640
Alexian Brothers Health System Hoffman Estates Illinois 60169
Lousiana Clinical Research, LLC Shreveport Louisiana 71104
Precise Research Center Flowood Mississippi 39232
St. Charles Psychiatric Associates-Midwest Research Saint Charles Missouri 63301
St. Louis Clinical Trials St Louis Missouri 63118
CRI Worldwide @ Lourdes Willingboro New Jersey 08046
Neurobehavioral Research Inc. Cedarhurst New York 11516
University of North Carolina at Chapel Hill Raleigh North Carolina 27603
Keystone Clinical Studies, LLC Norristown Pennsylvania 19401
Vanderbilt Heart and Vascular Institute Nashville Tennessee 37212
Community Clinical Research, Inc. Austin Texas 78754
Claghorn-Lesem Research Clinic, Inc. Houston Texas 77008

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00615433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2015 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00615433 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →